Skip to content
2000
image of Clinical Implications and Patient Outcomes Associated with Antibiotic Resistance in Saudi Arabian Intensive Care Unit Facilities: A Perspective

Abstract

Introduction

Antimicrobial Resistance (AMR) poses a significant global health threat, leading to increased morbidity, mortality, and healthcare costs. Intensive Care Units (ICUs) are particularly susceptible to AMR due to frequent invasive procedures, extended hospital stays, and the selective pressure exerted by broad-spectrum antibiotics. This review aims to shed light on the current landscape of antibiotic resistance within ICUs of Saudi hospitals. It also explores molecular patterns of bacterial resistance and identifies potential strategies to address this issue. Additionally, it discusses the challenges in implementing these strategies within the Saudi healthcare system.

Methods

We conducted a literature search across electronic databases, including Web of Science, PubMed, EMBASE, Scopus, and Google Scholar, until September 30th, 2024, to identify relevant studies. Selected studies were analyzed to extract insights into prevailing bacterial resistance trends in Saudi ICUs and the molecular mechanisms responsible.

Results

Our findings provide an overview of the current state of AMR in Saudi ICUs, including the emergence and prevalence of specific molecular patterns of bacterial resistance. Moreover, it presents potential strategies to combat antibiotic resistance, including antimicrobial stewardship programs, infection control measures, and the development of new antibiotics. It also highlights the inherent challenges in implementing these strategies within the unique healthcare landscape of Saudi Arabia.

Discussion

The increasing emergence and spread of MDR bacteria in Saudi Arabia are attributed to the unoptimized antibiotic use, over-the-counter antibiotics without prescription, a high volume of international travellers, and challenges in adherence to infection control practices. Addressing the challenges and implementing effective prevention strategies are critical to maintaining antibiotic efficacy and combating AMR. Several strategies have been employed by the National AMR Committee, in partnership with WHO, to address antibiotic resistance in intensive care units.

Conclusion

AMR in Saudi ICUs is a pressing concern requiring immediate attention. A multifaceted approach combining surveillance, education, and policy interventions is essential to overcome this issue. Addressing AMR is crucial for global efforts to preserve the efficacy of antibiotics and maintain the effectiveness of critical healthcare interventions.

© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode.
Loading

Article metrics loading...

/content/journals/crcep/10.2174/0127724328391436250902082555
2025-09-03
2025-11-29
Loading full text...

Full text loading...

/deliver/fulltext/crcep/10.2174/0127724328391436250902082555/BMS-CRCEP-2025-34.html?itemId=/content/journals/crcep/10.2174/0127724328391436250902082555&mimeType=html&fmt=ahah

References

  1. Health care-associated infections fact sheet. 2024 Available from: https://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf Accessed on 26 April 2024
  2. World health organization: Antimicrobial resistance. 2025 Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance Accessed on 22 April 2025
  3. Institute for health metrics and evaluation. 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/Saudi_Arabia.pdf Accessed on 22 April 2025
  4. Institute for Health Metrics and Evaluation: Burden of antimicrobial resistance (AMR) in Iran (Islamic Republic of). 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/Iran.pdf Accessed on 22 April 2025
  5. Institute for health metrics and evaluation: Burden of antimicrobial resistance (AMR) in Iraq. 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/Iraq.pdf Accessed on 22 April 2025
  6. Institute for health metrics and evaluation: Burden of antimicrobial resistance (AMR) in Oman. 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/Oman.pdf Accessed on 22 April 2025
  7. Institute for health metrics and evaluation: Burden of antimicrobial resistance (AMR) in Kuwait. 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/Kuwait.pdf Accessed on 22 April 2025
  8. Institute for health metrics and evaluation: Burden of antimicrobial resistance (AMR) in UAE. 2025 Available from: https://www.healthdata.org/sites/default/files/2023-09/UAE.pdf Accessed on 22 April 2025
  9. Mancuso G. Midiri A. Gerace E. Biondo C. Bacterial antibiotic resistance: The most critical pathogens. Pathogens 2021 10 10 1310 10.3390/pathogens10101310 34684258
    [Google Scholar]
  10. Mallah N. Orsini N. Figueiras A. Takkouche B. Income level and antibiotic misuse: A systematic review and dose–response meta-analysis. Eur. J. Health Econ. 2022 23 6 1015 1035 10.1007/s10198‑021‑01416‑8 34845563
    [Google Scholar]
  11. Tajeddin E. Rashidan M. Razaghi M. Javadi S.S.S. Sherafat S.J. Alebouyeh M. Sarbazi M.R. Mansouri N. Zali M.R. The role of the intensive care unit environment and health-care workers in the transmission of bacteria associated with hospital acquired infections. J. Infect. Public Health 2016 9 1 13 23 10.1016/j.jiph.2015.05.010 26117707
    [Google Scholar]
  12. Alhur A. Alhur A. Alfayiz A. Alotaibi A. Hansh B. Ghasib N. Alharbi F. Albalawi N. Aljohani A. Almaghthawi A. Sahlool A. AlThobaiti S. Hakami W. Alghamdi A. Asiri Z. Patterns and prevalence of self-medication in Saudi Arabia: Insights from a nationwide survey. Cureus 2023 15 12 e51281 10.7759/cureus.51281 38283451
    [Google Scholar]
  13. AlGhofaili F. Patterns of self-medication in Qassim Province, Saudi Arabia: A cross-sectional study. Ann. Med. Surg. 2021 64 102207 10.1016/j.amsu.2021.102207 33786166
    [Google Scholar]
  14. Al-Ghamdi S. Alfauri T.M. Alharbi M.A. Alsaihati M.M. Alshaykh M.M. Alharbi A.A. Aljaizani N.S. Allehiby I.A. Alzahrani M.A. Alharbi A.S. Current self-medication practices in the Kingdom of Saudi Arabia (KSA): An observational study. Pan Afr. Med. J. 2020 37 51 10.11604/pamj.2020.37.51.24098 33209178
    [Google Scholar]
  15. Lotfinejad N. Peters A. Tartari E. Fankhauser-Rodriguez C. Pires D. Pittet D. Hand hygiene in health care: 20 years of ongoing advances and perspectives. Lancet Infect. Dis. 2021 21 8 e209 e221 10.1016/S1473‑3099(21)00383‑2 34331890
    [Google Scholar]
  16. Cassini A. Plachouras D. Eckmanns T. Abu Sin M. Blank H.P. Ducomble T. Haller S. Harder T. Klingeberg A. Sixtensson M. Velasco E. Weiß B. Kramarz P. Monnet D.L. Kretzschmar M.E. Suetens C. Burden of six healthcare-associated infections on European population health: Estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016 13 10 e1002150 10.1371/journal.pmed.1002150 27755545
    [Google Scholar]
  17. Bassetti M. Righi E. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections. Curr. Opin. Crit. Care 2015 21 5 402 411 10.1097/MCC.0000000000000235 26263298
    [Google Scholar]
  18. Luyt C.E. Bréchot N. Trouillet J.L. Chastre J. Antibiotic stewardship in the intensive care unit. Crit. Care 2014 18 5 480 10.1186/s13054‑014‑0480‑6 25405992
    [Google Scholar]
  19. Ait Ouakrim D. Cassini A. Cecchini M. Plachouras D. North J. The health and economic burden of antimicrobial resistance. Challenges to Tackling Antimicrobial Resistance: Economic and Policy Responses. Cambridge Cambridge University Press 2020 23 44 10.1017/9781108864121.003
    [Google Scholar]
  20. Clean care is safer care: A global perspective. 2024 Available from: https://www.who.int/gpsc/5may/background/5moments/en/ Accessed on 26 April 2024
  21. Healthcare-associated infections. 2024 Available from: https://www.cdc.gov/hai/index.html Accessed on 26 April 2024
  22. Farah S.M. Alshehri M.A. Alfawaz T.S. Alasmeri F.A. Alageel A.A. Alshahrani D.A. Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia. Saudi Med. J. 2019 40 3 252 259 10.15537/smj.2019.3.23947 30834420
    [Google Scholar]
  23. Gaid E. Assiri A. McNabb S. Banjar W. Device-associated nosocomial infection in general hospitals, Kingdom of Saudi Arabia, 2013–2016. J. Epidemiol. Glob. Health 2017 7 S1 S35 S40.(Suppl. 1) 10.1016/j.jegh.2017.10.008 29801591
    [Google Scholar]
  24. Torumkuney D. Dolgum S. van Hasselt J. Abdullah W. Keles N. Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: Links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J. Antimicrob. Chemother. 2022 77 i70 i76.(Suppl. 1) 10.1093/jac/dkac219 36065727
    [Google Scholar]
  25. Al-Tawfiq J.A. Amalraj A. Memish Z.A. Reduction and surveillance of device-associated infections in adult intensive care units at a Saudi Arabian hospital, 2004–2011. Int. J. Infect. Dis. 2013 17 12 e1207 e1211 10.1016/j.ijid.2013.06.015 23932872
    [Google Scholar]
  26. Alslamah T. Abalkhail A. The national strategies for and challenges in infection prevention and control of the healthcare system in the Kingdom of Saudi Arabia (Review Study). Vaccines 2022 10 8 1302 10.3390/vaccines10081302 36016190
    [Google Scholar]
  27. Abdel-Fattah M.M. Surveillance of nosocomial infections at a Saudi Arabian military hospital for a one-year period. Ger. Med. Sci. 2005 3 Doc06 19675723
    [Google Scholar]
  28. Balkhy H.H. Cunningham G. Chew F.K. Francis C. Al Nakhli D.J. Almuneef M.A. Memish Z.A. Hospital- and community-acquired infections: A point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int. J. Infect. Dis. 2006 10 4 326 333 10.1016/j.ijid.2005.06.013 16678467
    [Google Scholar]
  29. Abalkhail A. Al Imam M.H. Elmosaad Y.M. Jaber M.F. Hosis K.A. Alhumaydhi F.A. Alslamah T. Alamer A. Mahmud I. Knowledge, attitude and practice of standard infection control precautions among health-care workers in a university hospital in Qassim, Saudi Arabia: A cross-sectional survey. Int. J. Environ. Res. Public Health 2021 18 22 11831 10.3390/ijerph182211831 34831585
    [Google Scholar]
  30. Mahfouz A.A. El Gamal M.N. Al-Azraqi T.A. Hand hygiene non-compliance among intensive care unit health care workers in Aseer Central Hospital, south-western Saudi Arabia. Int. J. Infect. Dis. 2013 17 9 e729 e732 10.1016/j.ijid.2013.02.025 23602356
    [Google Scholar]
  31. Alqahtani F. Khan A. Alowais J. Alaama T. Jokhdar H. Bed surge capacity in Saudi hospitals during the COVID-19 pandemic. Disaster Med. Public Health Prep. 2022 16 6 2446 2452 10.1017/dmp.2021.117 33866983
    [Google Scholar]
  32. Alghamdi S. Berrou I. Aslanpour Z. Mutlaq A. Haseeb A. Albanghali M. Hammad M.A. Shebl N. Antimicrobial stewardship programmes in Saudi hospitals: Evidence from a national survey. Antibiotics 2021 10 2 193 10.3390/antibiotics10020193 33671401
    [Google Scholar]
  33. Alshamrani M.M. El-Saed A. Alsaedi A. El Gammal A. Al Nasser W. Nazeer S. Balkhy H.H. Burden of healthcare-associated infections at six tertiary-care hospitals in Saudi Arabia: A point prevalence survey. Infect. Control Hosp. Epidemiol. 2019 40 3 355 357 10.1017/ice.2018.338 30777580
    [Google Scholar]
  34. Al-Tawfiq J.A. Memish Z.A. The emergence, persistence, and dissemination of antimicrobial-resistant bacteria in environmental Hajj settings and implications for public health. Trop. Med. Infect. Dis. 2021 6 1 33 10.3390/tropicalmed6010033 33802167
    [Google Scholar]
  35. Dahal M. Schwan W.R. Management of methicillin-resistant Staphylococcus aureus mediated ventilator-associated pneumonia. Curr. Trends Microbiol. 2018 12 95 107 31341354
    [Google Scholar]
  36. Alrefaei A.F. Almaleki D. Alshehrei F. Kadasah S. ALluqmani Z. Abdulaziz alotaibi Alsulaimani A. Aljuhani A. Alruhaili A. Assessment of health awareness and knowledge toward SARS-CoV-2 and COVID-19 vaccines among residents of Makkah, Saudi Arabia. Clin. Epidemiol. Glob. Health 2022 13 100935 10.1016/j.cegh.2021.100935 34934849
    [Google Scholar]
  37. El Amin N.M. Faidah H.S. Methicillin-resistant Staphylococcus aureus in the western region of Saudi Arabia: Prevalence and antibiotic susceptibility pattern. Ann. Saudi Med. 2012 32 5 513 516 10.5144/0256‑4947.2012.513 22871621
    [Google Scholar]
  38. Dantas Palmeira J. Ferreira H.M.N. Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in cattle production – A threat around the world. Heliyon 2020 6 1 e03206 10.1016/j.heliyon.2020.e03206 32042963
    [Google Scholar]
  39. Hassan S.A. Gherbawy Y.A. Altalhi A.D. Genetic heterogeneity of CTX-M type extended-spectrum β-lactamase producing Escherichia coli strains from diverse sources in Saudi Arabia. Int. Arab. J. Antimicrob. Agents 2015 5 2 10.3823/768
    [Google Scholar]
  40. Alotaibi F.E. Bukhari E.E. Al-Mohizea M.M. Hafiz T. Essa E.B. AlTokhais Y.I. Emergence of carbapenem-resistant Enterobacteriaceae isolated from patients in a university hospital in Saudi Arabia. Epidemiology, clinical profiles and outcomes. J. Infect. Public Health 2017 10 5 667 673 10.1016/j.jiph.2017.05.004 28642140
    [Google Scholar]
  41. Shorman M. Al-Tawfiq J.A. Risk factors associated with vancomycin-resistant enterococcus in intensive care unit settings in saudi arabia. Interdiscip. Perspect. Infect. Dis. 2013 2013 1 4 10.1155/2013/369674 24027580
    [Google Scholar]
  42. Ibrahim M.E. Prevalence of Acinetobacter baumannii in Saudi Arabia: Risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann. Clin. Microbiol. Antimicrob. 2019 18 1 1 10.1186/s12941‑018‑0301‑x 30606201
    [Google Scholar]
  43. Al-Orphaly M. Hadi H.A. Eltayeb F.K. Al-Hail H. Samuel B.G. Sultan A.A. Skariah S. Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the middle east and north Africa region. MSphere 2021 6 3 e00202-21 10.1128/mSphere.00202‑21 34011686
    [Google Scholar]
  44. Al-Zalabani A. AlThobyane O.A. Alshehri A.H. Alrehaili A.O. Namankani M.O. Aljafri O.H. Prevalence of Klebsiella pneumoniae antibiotic resistance in Medina, Saudi Arabia, 2014-2018. Cureus 2020 12 8 e9714 10.7759/cureus.9714 32944436
    [Google Scholar]
  45. Al Mayahi Z. Kamel S. Amer H. Beatty M. Outbreak of colistin-resistant organisms at a tertiary hospital in Riyadh, Saudi Arabia, 2016. Pan Afr. Med. J. 2019 34 162 10.11604/pamj.2019.34.162.19998 32153702
    [Google Scholar]
  46. Jalil M.B. Al Atbee M.Y.N. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. J. Clin. Lab. Anal. 2022 36 9 e24619 10.1002/jcla.24619 35870190
    [Google Scholar]
  47. Ali M.A. Rajab A.M. Al-Khani A.M. Ayash S.Q. Basha A.C. Abdelgadir A. Rajab T.M. Enabi S. Saquib N. Methicillin-resistant Staphylococcus aureus development in intensive care patients. Saudi Med. J. 2020 41 11 1181 1186 10.15537/smj.2020.11.25465 33130837
    [Google Scholar]
  48. Al-Hamad A.M. Alfaraj A.A. Altowaileb J. Al-Shamlan S.M. Leskafi H. Alsubeikhy F.A. Abbas H.R. Incidence and antibiotic susceptibility of MRSA infections in a Saudi Arabian Hospital: A 10-year surveillance study. J. Infect. Dev. Ctries. 2018 12 6 454 461 10.3855/jidc.9778 31940297
    [Google Scholar]
  49. Alhunaif S.A. Almansour S. Almutairi R. Alshammari S. Alkhonain L. Alalwan B. Aljohani S. Alsaedy A. Bosaeed M. Alothman A. Methicillin-resistant staphylococcus aureus bacteremia: Epidemiology, clinical characteristics, risk factors, and outcomes in a tertiary care center in Riyadh, Saudi Arabia. Cureus 2021 13 5 e14934 10.7759/cureus.14934 34123631
    [Google Scholar]
  50. Aldrazi F.A. Rabaan A.A. Alsuliman S.A. Aldrazi H.A. Alabdalslam M.J. Alsadiq S.A. Alhani H.M. Bueid A.S. ESBL expression and antibiotic resistance patterns in a hospital in Saudi Arabia: Do healthcare staff have the whole picture? J. Infect. Public Health 2020 13 5 759 766 10.1016/j.jiph.2019.12.001 31901487
    [Google Scholar]
  51. Ibrahim M.E. Abbas M. Al-Shahrai A.M. Elamin B.K. Phenotypic characterization and antibiotic resistance patterns of extended-spectrum β -Lactamase- and AmpC β -lactamase-producing gram-negative bacteria in a referral hospital, Saudi Arabia. Can. J. Infect. Dis. Med. Microbiol. 2019 2019 6054694 10.1155/2019/6054694 31346353
    [Google Scholar]
  52. El-Masry EA Alruwaili FM Taha AE Saad AE Taher IA Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae among clinical isolates in Turaif general hospital, northern borders- Saudi Arabia. J. Infect. Dev. Ctries. 2023 17 4 477 484 10.3855/jidc.17212
    [Google Scholar]
  53. Ahmed Kabrah Extended-spectrum beta-lactamase and carbapenem-resistant gram-negative pathogens in Makkah, Saudi Arabia. Ethiop. J. Health Sci. 2022 32 6 1221 1230 10.4314/ejhs.v32i6.20 36475249
    [Google Scholar]
  54. Alraddadi B.M. Heaphy E.L.G. Aljishi Y. Ahmed W. Eljaaly K. Al-Turkistani H.H. Alshukairi A.N. Qutub M.O. Alodini K. Alosaimi R. Hassan W. Attalah D. Alswaiel R. Saeedi M.F. Al-Hamzi M.A. Hefni L.K. Almaghrabi R.S. Anani M. Althaqafi A. Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia. BMC Infect. Dis. 2022 22 1 542 10.1186/s12879‑022‑07507‑y 35698046
    [Google Scholar]
  55. Abdalhamid B. Elhadi N. Alabdulqader N. Alsamman K. Aljindan R. Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia. New Microbes New Infect. 2016 10 77 83 10.1016/j.nmni.2016.01.014 26933499
    [Google Scholar]
  56. Alzomor O.A. Alfawaz T.S. Abu-Shaheen A. Alshehri M.A. Shahrani D.A. A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia. Saudi Med. J. 2019 40 11 1105 1110 10.15537/smj.2019.11.24586 31707406
    [Google Scholar]
  57. Taha R. Mowallad A. Mufti A. Althaqafi A. Fatani A.A. El-Hossary D. Ossenkopp J. AlhajHussein B. Kaaki M. Jawi N. Hassanien A. Alsaedi A. Prevalence of Carbapenem-Resistant Enterobacteriaceae in Western Saudi Arabia and Increasing Trends in the Antimicrobial Resistance of Enterobacteriaceae. Cureus 2023 15 2 e35050 10.7759/cureus.35050 36942194
    [Google Scholar]
  58. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2025 Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed Accessed on 14 January 2025
  59. Zilahi G. Artigas A. Martin-Loeches I. What’s new in multidrug-resistant pathogens in the ICU? Ann. Intensive Care 2016 6 1 96 10.1186/s13613‑016‑0199‑4 27714706
    [Google Scholar]
  60. Alkofide H. Alhammad A.M. Alruwaili A. Aldemerdash A. Almangour T.A. Alsuwayegh A. Almoqbel D. Albati A. Alsaud A. Enani M. Multidrug-resistant and extensively drug-resistant enterobacteriaceae: prevalence, treatments, and outcomes – A retrospective cohort study. Infect. Drug Resist. 2020 13 4653 4662 10.2147/IDR.S283488 33380815
    [Google Scholar]
  61. Almaghrabi M.K. Joseph M.R.P. Assiry M.M. Hamid M.E. Multidrug-resistant Acinetobacter baumannii : An emerging health threat in Aseer Region, Kingdom of Saudi Arabia. Can. J. Infect. Dis. Med. Microbiol. 2018 2018 1 4 10.1155/2018/9182747 29623140
    [Google Scholar]
  62. Alhussain F.A. Yenugadhati N. Al Eidan F.A. Al Johani S. Badri M. Risk factors, antimicrobial susceptibility pattern and patient outcomes of Pseudomonas aeruginosa infection: A matched case-control study. J. Infect. Public Health 2021 14 1 152 157 10.1016/j.jiph.2020.11.010 33422856
    [Google Scholar]
  63. Ibrahim M.E. Risk factors in acquiring multidrug-resistant Klebsiella pneumoniae infections in a hospital setting in Saudi Arabia. Sci. Rep. 2023 13 1 11626 10.1038/s41598‑023‑38871‑7 37468757
    [Google Scholar]
  64. Alotaibi F.E. Bukhari E.E. Emergence of Vancomycin-resistant enterococci at a teaching hospital, Saudi Arabia. Chin. Med. J. 2017 130 3 340 346 10.4103/0366‑6999.198923 28139519
    [Google Scholar]
  65. Darby E.M. Trampari E. Siasat P. Gaya M.S. Alav I. Webber M.A. Blair J.M.A. Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol. 2023 21 5 280 295 10.1038/s41579‑022‑00820‑y 36411397
    [Google Scholar]
  66. Carattoli A. Plasmids and the spread of resistance. Int. J. Med. Microbiol. 2013 303 6-7 298 304 10.1016/j.ijmm.2013.02.001 23499304
    [Google Scholar]
  67. Partridge S.R. Kwong S.M. Firth N. Jensen S.O. Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 2018 31 4 e00088-17 10.1128/CMR.00088‑17 30068738
    [Google Scholar]
  68. Schulze A. Mitterer F. Pombo J.P. Schild S. Biofilms by bacterial human pathogens: Clinical relevance - development, composition and regulation - therapeutical strategies. Microb. Cell 2021 8 2 28 56 10.15698/mic2021.02.741 33553418
    [Google Scholar]
  69. Ibrahim M.E. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. Saudi Med. J. 2018 39 10 1035 1043 10.15537/smj.2018.10.22944 30284588
    [Google Scholar]
  70. Kharaba A. Abdelaziz Hussein M.A. Al-Hameed F. Mandourah Y. Almekhlafi G. Algethamy H. Hamdan A. Azem M.A. Fatani J. al Beshabshe A. Yousif A. Dorsi H. Al Hazmi A. Al Motairi A. Alshahrani M. Arabi Y.M. Acinetobacter baumanniiin Saudi Arabia: The new growing threat. Saudi Crit. Care J 2019 3 1 54 10.4103/2543‑1854.259469
    [Google Scholar]
  71. Al-Obeid S. Jabri L. Al-Agamy M. Al-Omari A. Shibl A. Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA). J. Chemother. 2015 27 3 156 162 10.1179/1973947815Y.0000000019 25867622
    [Google Scholar]
  72. Saeed N.K. Kambal A.M. El-Khizzi N.A. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med. J. 2010 31 12 1341 1349 21135998
    [Google Scholar]
  73. Lima J.L.C. Alves L.R. Paz J.N.P. Rabelo M.A. Maciel M.A.V. Morais M.M.C. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-associated pneumonia. Rev. Bras. Ter. Intensiva 2017 29 3 310 316 10.5935/0103‑507X.20170039 28876402
    [Google Scholar]
  74. Latifpour M. Narimani T. Sadeghi A. Niakan M. Determination of virulence factors and resistance profile of methicillin-resistant Staphylococcus aureus strains among different types of spa, agr, and SCCmec. BioMed Res. Int. 2022 2022 1 5863310 10.1155/2022/5863310 36281464
    [Google Scholar]
  75. Najar-Peerayeh S. Jazayeri Moghadas A. Behmanesh M. Antibiotic susceptibility and mecA frequency in Staphylococcus epidermidis , isolated from intensive care unit patients. Jundishapur J. Microbiol. 2014 7 7 e11188 10.5812/jjm.11188 25485050
    [Google Scholar]
  76. Abd El Hafez M. Khalaf N.G. El Ahmady M. Abd El Aziz A. Hashim A.E.G. An outbreak of methicillin resistant Staphylococcus epidermidis among neonates in a hospital in Saudi Arabia. J. Infect. Dev. Ctries. 2011 5 10 692 699 10.3855/jidc.1293 21997937
    [Google Scholar]
  77. Miragaia M. Factors contributing to the evolution of mecA -mediated β-lactam resistance in Staphylococci: Update and new insights from whole genome sequencing (WGS). Front. Microbiol. 2018 9 2723 10.3389/fmicb.2018.02723 30483235
    [Google Scholar]
  78. Almogbel M. Altheban A. Alenezi M. Al-Motair K. Menezes G.A. Elabbasy M. Hammam S. Hays J.P. Khan M.A. CTX-M-15 positive Escherichia coli and Klebsiella pneumoniae outbreak in the neonatal intensive care unit of a maternity hospital in Ha’il, Saudi Arabia. Infect. Drug Resist. 2021 14 2843 2849 10.2147/IDR.S317079 34326652
    [Google Scholar]
  79. Singh N. Pattnaik D. Neogi D.K. Jena J. Mallick B. Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. J. Clin. Diagn. Res. 2016 10 9 DC19 DC22 10.7860/JCDR/2016/21260.8544 27790433
    [Google Scholar]
  80. Abalkhail A. AlYami A.S. Alrashedi S.F. Almushayqih K.M. Alslamah T. Alsalamah Y.A. Elbehiry A. The prevalence of multidrug-resistant Escherichia coli producing ESBL among male and female patients with urinary tract infections in Riyadh region, Saudi Arabia. Healthcare 2022 10 9 1778 10.3390/healthcare10091778 36141390
    [Google Scholar]
  81. Al-Agamy M.H. Shibl A.M. Hafez M.M. Al-Ahdal M.N. Memish Z.A. Khubnani H. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. Ann. Clin. Microbiol. Antimicrob. 2014 13 1 4 10.1186/1476‑0711‑13‑4 24397567
    [Google Scholar]
  82. Alyamani E.J. Khiyami A.M. Booq R.Y. Majrashi M.A. Bahwerth F.S. Rechkina E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 2017 16 1 1 10.1186/s12941‑016‑0177‑6 28061852
    [Google Scholar]
  83. Yasir M. Subahi A.M. Shukri H.A. Bibi F. Sohrab S.S. Alawi M. Sindi A.A. Jiman-Fatani A.A. Azhar E.I. Bacterial community and genomic analysis of carbapenem-resistant Acinetobacter baumannii isolates from the environment of a health care facility in the western region of Saudi Arabia. Pharmaceuticals 2022 15 5 611 10.3390/ph15050611 35631436
    [Google Scholar]
  84. Lopes B.S. Al-Agamy M.H. Ismail M.A. Shibl A.M. Al-Qahtani A.A. Al-Ahdal M.N. Forbes K.J. The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt. Int. J. Med. Microbiol. 2015 305 6 581 588 10.1016/j.ijmm.2015.07.007 26253451
    [Google Scholar]
  85. Girlich D. Poirel L. Nordmann P. First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrob. Agents Chemother. 2010 54 1 578 579 10.1128/AAC.00861‑09 19884362
    [Google Scholar]
  86. Hem S. Wyrsch E.R. Drigo B. Baker D.J. Charles I.G. Donner E. Jarocki V.M. Djordjevic S.P. Genomic Analysis of Carbapenem-Resistant Comamonas in Water Matrices: Implications for public health and wastewater treatments. Appl. Environ. Microbiol. 2022 88 13 e00646-22 10.1128/aem.00646‑22 35708324
    [Google Scholar]
  87. Surveillance in emergencies. 2023 Available from: https://www.who.int/emergencies/surveillance Accessed on:22 April 2025. 2023
  88. Ibrahim M. Algak T. Abbas M. Elamin B. Emergence of bla TEM , bla CTX‑M , bla SHV and bla OXA genes in multidrug‑resistant Enterobacteriaceae and Acinetobacter baumannii in Saudi Arabia. Exp. Ther. Med. 2021 22 6 1450 10.3892/etm.2021.10885 34721692
    [Google Scholar]
  89. Zowawi H.M. Antimicrobial resistance in Saudi Arabia. Saudi Med. J. 2016 37 9 935 940 10.15537/smj.2016.9.16139 27570847
    [Google Scholar]
  90. Kingdom of Saudi Arabia: Second antimicrobial resistance action plan 2022-2025. 2022 Available from: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/kingdom-of-saudi-arabia-nap-amr-2022-2025.pdf?sfvrsn=722aaed5_3&download=true Accessed on 01 February 2024.
  91. Partner in global health: The strategic partnership with The Kingdom of Saudi Arabia. 2025 Available from: https://www.who.int/about/funding/contributors/kingdom-of-saudi-arabia Accessed on 22 April 2025.
  92. Hatcher J. Dhillon R. Azadian B.S. Antibiotic resistance mechanisms in the intensive care unit. J. Intensive Care Soc. 2012 13 4 297 303 10.1177/175114371201300407
    [Google Scholar]
  93. Global Antimicrobial Resistance Surveillance System (GLASS). 2023 Available from: https://iris.who.int/bitstream/handle/10665/259744/9789241513449-eng.pdf?sequence=1
  94. Thabit A.K. Alabbasi A.Y. Alnezary F.S. Almasoudi I.A. An overview of antimicrobial resistance in Saudi Arabia (2013–2023) and the need for national surveillance. Microorganisms 2023 11 8 2086 10.3390/microorganisms11082086 37630646
    [Google Scholar]
  95. Infection prevention and control. 2021 Available from: https://www.who.int/health-topics/infection-prevention-and-control#tab=tab_1 . Accessed on 22 April 2025.
  96. Aleanizy F.S. Alqahtani F.Y. Risk management and infection control preparedness of Saudi healthcare facilities to overcome the COVID-19 pandemic. IJID Reg. 2022 3 268 274 10.1016/j.ijregi.2022.04.005 35720150
    [Google Scholar]
  97. Almalag H.M. Al-Yamani M.J. Alsalloum H.F. An exploration of the public’s attitude toward antibiotic use and prescription in light of the recent ministry of health regulations: A cross-sectional study in the Kingdom of Saudi Arabia. Healthcare 2022 10 8 1520 10.3390/healthcare10081520 36011176
    [Google Scholar]
  98. Alnasser A.H.A. Al-Tawfiq J.A. Ahmed H.A.A. Alqithami S.M.H. Alhaddad Z.M.A. Rabiah A.S.M. Albrahim M.A.A. Al Kalif M.S.H. Barry M. Temsah M.H. Al-Kalaif Z.S.H. Shahadah R.F.B. Alharbi K.K.S. Alnasser A.A.H. Public knowledge, attitude and practice towards antibiotics use and antimicrobial resistance in Saudi Arabia: A web-based cross-sectional survey. J. Public Health Res. 2021 10 4 jphr.2021.2276 10.4081/jphr.2021.2276 34313091
    [Google Scholar]
  99. Ministry of Health (2018): Ministry of health warns against selling antibiotics without prescription. 2018 Available from: https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/news-2018-04-17-004.aspx
  100. Alzahrani K.O. Alshahrani S.M. Alajel S.M. Evaluating the effectiveness of the Ministry of Health restriction policy on seasonal antibiotic consumption trends in Saudi Arabia, 2016–2020. Front. Pharmacol. 2023 14 1242087 10.3389/fphar.2023.1242087 38099146
    [Google Scholar]
  101. Health workforce education and training. 2019 Available from: https://www.who.int/activities/health-workforce-education-and-training
  102. Majumder M.A.A. Rahman S. Cohall D. Bharatha A. Singh K. Haque M. Gittens-St Hilaire M. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infect. Drug Resist. 2020 13 4713 4738 10.2147/IDR.S290835 33402841
    [Google Scholar]
  103. Haseeb A. Faidah H.S. Al-Gethamy M. Iqbal M.S. Alhifany A.A. Ali M. Almarzoky Abuhussain S.S. Elrggal M.E. Almalki W.H. Alghamdi S. Saleem Z. Verma A.K. Algarni M.A. Ashgar S.S. Qashqari F.S.I. Hassali M.A. Evaluation of Antimicrobial Stewardship Programs (ASPs) and their perceived level of success at Makkah region hospitals, Kingdom of Saudi Arabia. Saudi Pharm. J. 2020 28 10 1166 1171 10.1016/j.jsps.2020.08.005 33132709
    [Google Scholar]
  104. Amer M.R. Akhras N.S. Mahmood W.A. Al-Jazairi A.S. Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia. Ann. Saudi Med. 2013 33 6 547 554 10.5144/0256‑4947.2013.547 24413857
    [Google Scholar]
  105. Haseeb A. Faidah H.S. Al-Gethamy M. Iqbal M.S. Barnawi A.M. Elahe S.S. Bukhari D.N. Noor Al-Sulaimani T.M. Fadaaq M. Alghamdi S. Almalki W.H. Saleem Z. Elrggal M.E. Khan A.H. Algarni M.A. Ashgar S.S. Hassali M.A. Evaluation of a multidisciplinary antimicrobial stewardship program in a Saudi critical care unit: A quasi-experimental study. Front. Pharmacol. 2021 11 570238 10.3389/fphar.2020.570238 33776750
    [Google Scholar]
  106. Alzahrani W.M. Alkliakh L.S. Alwafai E.B. Madani M.F. Hersi N.L. Shakir E.A. Thabit A.K. Awareness of antimicrobial resistance and appropriate handling of antibiotics by the public in Saudi Arabia: A cross-sectional study using a quiz game. PEC Innov. 2024 5 100318 10.1016/j.pecinn.2024.100318 39076852
    [Google Scholar]
  107. Alghamdi S. Atef-Shebl N. Aslanpour Z. Berrou I. Barriers to implementing antimicrobial stewardship programmes in three Saudi hospitals: Evidence from a qualitative study. J. Glob. Antimicrob. Resist. 2019 18 284 290 10.1016/j.jgar.2019.01.031 30797087
    [Google Scholar]
  108. Darraj A. Almutairi M. Alhassan O. Aljammaz A. Almansour I. Alotaibi S. Abohelaibah F. Alseleem A. Alsumayt A. Alarifi O. Alabdullatif G. Almutairi F. Tabish M. Attitudes and practices of physicians toward law enforcement on dispensing antibiotics without prescription antibiotics: Findings from a cross-sectional survey. J. Family Med. Prim. Care 2023 12 4 679 685 10.4103/jfmpc.jfmpc_1942_22 37312778
    [Google Scholar]
  109. Edelstein M. Lee L.M. Herten-Crabb A. Heymann D.L. Harper D.R. Strengthening global public health surveillance through data and benefit sharing. Emerg. Infect. Dis. 2018 24 7 1324 1330 10.3201/eid2407.151830
    [Google Scholar]
  110. Naghavi M. Vollset S.E. Ikuta K.S. Swetschinski L.R. Gray A.P. Wool E.E. Robles Aguilar G. Mestrovic T. Smith G. Han C. Hsu R.L. Chalek J. Araki D.T. Chung E. Raggi C. Gershberg Hayoon A. Davis Weaver N. Lindstedt P.A. Smith A.E. Altay U. Bhattacharjee N.V. Giannakis K. Fell F. McManigal B. Ekapirat N. Mendes J.A. Runghien T. Srimokla O. Abdelkader A. Abd-Elsalam S. Aboagye R.G. Abolhassani H. Abualruz H. Abubakar U. Abukhadijah H.J. Aburuz S. Abu-Zaid A. Achalapong S. Addo I.Y. Adekanmbi V. Adeyeoluwa T.E. Adnani Q.E.S. Adzigbli L.A. Afzal M.S. Afzal S. Agodi A. Ahlstrom A.J. Ahmad A. Ahmad S. Ahmad T. Ahmadi A. Ahmed A. Ahmed H. Ahmed I. Ahmed M. Ahmed S. Ahmed S.A. Akkaif M.A. Al Awaidy S. Al Thaher Y. Alalalmeh S.O. AlBataineh M.T. Aldhaleei W.A. Al-Gheethi A.A.S. Alhaji N.B. Ali A. Ali L. Ali S.S. Ali W. Allel K. Al-Marwani S. Alrawashdeh A. Altaf A. Al-Tammemi A.B. Al-Tawfiq J.A. Alzoubi K.H. Al-Zyoud W.A. Amos B. Amuasi J.H. Ancuceanu R. Andrews J.R. Anil A. Anuoluwa I.A. Anvari S. Anyasodor A.E. Apostol G.L.C. Arabloo J. Arafat M. Aravkin A.Y. Areda D. Aremu A. Artamonov A.A. Ashley E.A. Asika M.O. Athari S.S. Atout M.M.W. Awoke T. Azadnajafabad S. Azam J.M. Aziz S. Azzam A.Y. Babaei M. Babin F-X. Badar M. Baig A.A. Bajcetic M. Baker S. Bardhan M. Barqawi H.J. Basharat Z. Basiru A. Bastard M. Basu S. Bayleyegn N.S. Belete M.A. Bello O.O. Beloukas A. Berkley J.A. Bhagavathula A.S. Bhaskar S. Bhuyan S.S. Bielicki J.A. Briko N.I. Brown C.S. Browne A.J. Buonsenso D. Bustanji Y. Carvalheiro C.G. Castañeda-Orjuela C.A. Cenderadewi M. Chadwick J. Chakraborty S. Chandika R.M. Chandy S. Chansamouth V. Chattu V.K. Chaudhary A.A. Ching P.R. Chopra H. Chowdhury F.R. Chu D-T. Chutiyami M. Cruz-Martins N. da Silva A.G. Dadras O. Dai X. Darcho S.D. Das S. De la Hoz F.P. Dekker D.M. Dhama K. Diaz D. Dickson B.F.R. Djorie S.G. Dodangeh M. Dohare S. Dokova K.G. Doshi O.P. Dowou R.K. Dsouza H.L. Dunachie S.J. Dziedzic A.M. Eckmanns T. Ed-Dra A. Eftekharimehrabad A. Ekundayo T.C. El Sayed I. Elhadi M. El-Huneidi W. Elias C. Ellis S.J. Elsheikh R. Elsohaby I. Eltaha C. Eshrati B. Eslami M. Eyre D.W. Fadaka A.O. Fagbamigbe A.F. Fahim A. Fakhri-Demeshghieh A. Fasina F.O. Fasina M.M. Fatehizadeh A. Feasey N.A. Feizkhah A. Fekadu G. Fischer F. Fitriana I. Forrest K.M. Fortuna Rodrigues C. Fuller J.E. Gadanya M.A. Gajdács M. Gandhi A.P. Garcia-Gallo E.E. Garrett D.O. Gautam R.K. Gebregergis M.W. Gebrehiwot M. Gebremeskel T.G. Geffers C. Georgalis L. Ghazy R.M. Golechha M. Golinelli D. Gordon M. Gulati S. Gupta R.D. Gupta S. Gupta V.K. Habteyohannes A.D. Haller S. Harapan H. Harrison M.L. Hasaballah A.I. Hasan I. Hasan R.S. Hasani H. Haselbeck A.H. Hasnain M.S. Hassan I.I. Hassan S. Hassan Zadeh Tabatabaei M.S. Hayat K. He J. Hegazi O.E. Heidari M. Hezam K. Holla R. Holm M. Hopkins H. Hossain M.M. Hosseinzadeh M. Hostiuc S. Hussein N.R. Huy L.D. Ibáñez-Prada E.D. Ikiroma A. Ilic I.M. Islam S.M.S. Ismail F. Ismail N.E. Iwu C.D. Iwu-Jaja C.J. Jafarzadeh A. Jaiteh F. Jalilzadeh Yengejeh R. Jamora R.D.G. Javidnia J. Jawaid T. Jenney A.W.J. Jeon H.J. Jokar M. Jomehzadeh N. Joo T. Joseph N. Kamal Z. Kanmodi K.K. Kantar R.S. Kapisi J.A. Karaye I.M. Khader Y.S. Khajuria H. Khalid N. Khamesipour F. Khan A. Khan M.J. Khan M.T. Khanal V. Khidri F.F. Khubchandani J. Khusuwan S. Kim M.S. Kisa A. Korshunov V.A. Krapp F. Krumkamp R. Kuddus M. Kulimbet M. Kumar D. Kumaran E.A.P. Kuttikkattu A. Kyu H.H. Landires I. Lawal B.K. Le T.T.T. Lederer I.M. Lee M. Lee S.W. Lepape A. Lerango T.L. Ligade V.S. Lim C. Lim S.S. Limenh L.W. Liu C. Liu X. Liu X. Loftus M.J. M Amin H.I. Maass K.L. Maharaj S.B. Mahmoud M.A. Maikanti-Charalampous P. Makram O.M. Malhotra K. Malik A.A. Mandilara G.D. Marks F. Martinez-Guerra B.A. Martorell M. Masoumi-Asl H. Mathioudakis A.G. May J. McHugh T.A. Meiring J. Meles H.N. Melese A. Melese E.B. Minervini G. Mohamed N.S. Mohammed S. Mohan S. Mokdad A.H. Monasta L. Moodi Ghalibaf A.A. Moore C.E. Moradi Y. Mossialos E. Mougin V. Mukoro G.D. Mulita F. Muller-Pebody B. Murillo-Zamora E. Musa S. Musicha P. Musila L.A. Muthupandian S. Nagarajan A.J. Naghavi P. Nainu F. Nair T.S. Najmuldeen H.H.R. Natto Z.S. Nauman J. Nayak B.P. Nchanji G.T. Ndishimye P. Negoi I. Negoi R.I. Nejadghaderi S.A. Nguyen Q.A.P. Noman E.A. Nwakanma D.C. O’Brien S. Ochoa T.J. Odetokun I.A. Ogundijo O.A. Ojo-Akosile T.R. Okeke S.R. Okonji O.C. Olagunju A.T. Olivas-Martinez A. Olorukooba A.A. Olwoch P. Onyedibe K.I. Ortiz-Brizuela E. Osuolale O. Ounchanum P. Oyeyemi O.T. P A M.P. Paredes J.L. Parikh R.R. Patel J. Patil S. Pawar S. Peleg A.Y. Peprah P. Perdigão J. Perrone C. Petcu I-R. Phommasone K. Piracha Z.Z. Poddighe D. Pollard A.J. Poluru R. Ponce-De-Leon A. Puvvula J. Qamar F.N. Qasim N.H. Rafai C.D. Raghav P. Rahbarnia L. Rahim F. Rahimi-Movaghar V. Rahman M. Rahman M.A. Ramadan H. Ramasamy S.K. Ramesh P.S. Ramteke P.W. Rana R.K. Rani U. Rashidi M-M. Rathish D. Rattanavong S. Rawaf S. Redwan E.M.M. Reyes L.F. Roberts T. Robotham J.V. Rosenthal V.D. Ross A.G. Roy N. Rudd K.E. Sabet C.J. Saddik B.A. Saeb M.R. Saeed U. Saeedi Moghaddam S. Saengchan W. Safaei M. Saghazadeh A. Saheb Sharif-Askari N. Sahebkar A. Sahoo S.S. Sahu M. Saki M. Salam N. Saleem Z. Saleh M.A. Samodra Y.L. Samy A.M. Saravanan A. Satpathy M. Schumacher A.E. Sedighi M. Seekaew S. Shafie M. Shah P.A. Shahid S. Shahwan M.J. Shakoor S. Shalev N. Shamim M.A. Shamshirgaran M.A. Shamsi A. Sharifan A. Shastry R.P. Shetty M. Shittu A. Shrestha S. Siddig E.E. Sideroglou T. Sifuentes-Osornio J. Silva L.M.L.R. Simões E.A.F. Simpson A.J.H. Singh A. Singh S. Sinto R. Soliman S.S.M. Soraneh S. Stoesser N. Stoeva T.Z. Swain C.K. Szarpak L. T y S.S. Tabatabai S. Tabche C. Taha Z.M-A. Tan K-K. Tasak N. Tat N.Y. Thaiprakong A. Thangaraju P. Tigoi C.C. Tiwari K. Tovani-Palone M.R. Tran T.H. Tumurkhuu M. Turner P. Udoakang A.J. Udoh A. Ullah N. Ullah S. Vaithinathan A.G. Valenti M. Vos T. Vu H.T.L. Waheed Y. Walker A.S. Walson J.L. Wangrangsimakul T. Weerakoon K.G. Wertheim H.F.L. Williams P.C.M. Wolde A.A. Wozniak T.M. Wu F. Wu Z. Yadav M.K.K. Yaghoubi S. Yahaya Z.S. Yarahmadi A. Yezli S. Yismaw Y.E. Yon D.K. Yuan C-W. Yusuf H. Zakham F. Zamagni G. Zhang H. Zhang Z-J. Zielińska M. Zumla A. Zyoud S.H.H. Zyoud S.H. Hay S.I. Stergachis A. Sartorius B. Cooper B.S. Dolecek C. Murray C.J.L. Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. Lancet 2024 404 10459 1199 1226 10.1016/S0140‑6736(24)01867‑1 39299261
    [Google Scholar]
  111. Manyi-Loh C. Mamphweli S. Meyer E. Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: Potential public health implications. Molecules 2018 23 4 795 10.3390/molecules23040795 29601469
    [Google Scholar]
  112. Morel C.M. Lindahl O. Harbarth S. de Kraker M.E.A. Edwards S. Hollis A. Industry incentives and antibiotic resistance: An introduction to the antibiotic susceptibility bonus. J. Antibiot. 2020 73 7 421 428 10.1038/s41429‑020‑0300‑y 32203126
    [Google Scholar]
/content/journals/crcep/10.2174/0127724328391436250902082555
Loading
/content/journals/crcep/10.2174/0127724328391436250902082555
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test